1.
Bull Exp Biol Med
; 139(1): 24-6, 2005 Jan.
Artículo
en Inglés
| MEDLINE
| ID: mdl-16142267
RESUMEN
We studied the effect of Vilon in rats 2, 4, and 6 months after the onset of chronic renal failure. Subcutaneous injection of Vilon significantly decreased serum concentration of transforming growth factor-beta(1) and permeability of mesenteric microvessels in rats 2 months after the onset of chronic renal failure. Our results indicate that the preparation produces a potent homeostatic effect in the early period of chronic renal failure.